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Abstract
Background: Mercury is a toxic heavy metal and is known to affect many diseases. However, few studies have
examined the effects of mercury exposure on liver function in the general population. We examined the association
between blood mercury concentrations and liver enzyme levels in the elderly.
Methods: We included 560 elderly participants (60 years or older) who were recruited from 2008 to 2010 and followed
up to 2014. Subjects visited a community welfare center and underwent a medical examination and measurement of
mercury levels up to five times. Analyses using generalized estimating equations model were performed after adjusting
for age, sex, education, overweight, alcohol consumption, smoking, regular exercise, high-density lipoproteins
cholesterol, and total calorie intake. Additionally, we estimated interaction effects of alcohol consumption with
mercury and mediation effect of oxidative stress in the relationship between mercury levels and liver function.
Results: The geometric mean (95% confidence interval (CI)) of blood mercury concentrations was 2.81 μg/L
(2.73, 2.89). Significant relationships were observed between blood mercury concentrations and the level of
liver enzymes, including aspartate aminotransferase (AST), alanine aminotransferase (ALT), and gamma glutamyl
transferase (GGT), after adjusting for potential confounders (P < 0.05). The odds ratios of having abnormal ALT
levels were statistically significant in the highest mercury quartile compared to those with the lowest quartile.
Particularly, regular alcohol drinkers showed greater effect estimates of mercury on the liver function than
non-drinkers groups. There was no mediation effect of oxidative stress in the relationship between blood
mercury concentrations and liver function.
Conclusions: Our results suggest that blood mercury levels are associated with elevated liver enzymes and
interact with alcohol consumption for the association in the elderly.
Keywords: Mercury, Liver function test, Aged, Mercury alcohol interaction
Background
Mercury is a toxic heavy metal that causes various ad-
verse effects on health, including hypertension, cardio-
vascular disease, neurotoxicity and nephrotoxicity [1–3].
Mercury exists in various forms, including elemental (or
metallic), inorganic and organic (e.g., methylmercury),
which indicate multiple routes of exposure [4]. Mercury
enters the body through the air, food and water, and is
then distributed to all bodily tissues from the blood-
stream within 3 days and subsequently eliminated slowly
through feces and urine [5]. In the general population,
most blood mercury levels are considered to be from or-
ganic methylmercury through fish consumption [6]. The
half-life of total mercury is 57 ± 18 days in blood and 64
± 22 days in hair [7]. Mercury is secreted into bile and
partly reabsorbed by the liver through the portal vein in
biliary-hepatic cycling. The high mobility of mercury in
the body is due to the formation of a mercury-cysteine
complex attached to the sulfur atoms of thiol groups
(glutathione) in the bile duct and gall bladder [5, 8].
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A recent review suggested that mercury cause neuro-
logic disorders [9], cardiovascular disease [10], and
asthma in children [11]. In addition to evidence of mer-
cury effects on various organs, some animal studies have
suggested that acute mercury exposure can damage the
liver [12, 13]. However, the relationship between chronic
mercury exposure and liver-related outcomes in humans
is not well understood.
Epidemiologic studies of the association between mer-
cury exposure and liver function have shown inconsist-
ent results. A cross-sectional study in people who lived
near Minamata, which was highly polluted by methyl-
mercury, reported that the prevalence of liver disease
was not significantly higher than other areas with less
polluted level of methylmercury [14]. Poursafa et al. [15]
showed that aspartate aminotransaminase (AST) and
alanine aminotransaminase (ALT) did not increase sig-
nificantly with increased quartiles of blood mercury
levels. In contrast, Cave et al. [16] suggested a positive
association between blood mercury levels and ALT in
the US population. Lee et al. [17] showed an association
between blood mercury levels and AST and ALT in
2008–2012 Korean national health and nutrition exam-
ination survey (KNHANES), and Seo et al. [18] reported
an association between blood mercury levels and γ-
glutamyl transferase (GGT) in 2010 KNHANES. All of
these previous studies used a cross-sectional design
based on a single measurement of blood mercury and
liver enzyme, which does not capture intra-individual
variation of the association between mercury levels and
liver dysfunction. Therefore, panel study, detecting
within-person changes across time and increasing statis-
tical power by repeatedly measuring the levels of mer-
cury and liver enzymes, was better than single-measured
cross-sectional study. A recent study reported that eld-
erly adults, particularly those aged 60–69 years and
Asians residing in the US communities had the highest
exposure prevalence of methylmercury according to the
National Health and Nutrition Examination Survey
(NHANES) 2011–2012 [19]. In the Korea National
Health and Nutrition Examination Survey (KNHANES,
2008–2012), mean values of blood mercury concentra-
tion were 5.07 ± 0.07 μg/L in males and 3.59 ± 0.04 μg/L
in females [20] and they were higher than NHANES.
Therefore, there is a need to investigate the elderly
Asians vulnerable to mercury exposure for the associ-
ation with liver function.
The objective of this study was to determine the asso-
ciation between blood mercury concentrations and liver
enzyme levels (AST, ALT, and GGT) using repeated
measurements in an elderly population. In addition, we
investigated the interaction of alcohol consumption and
blood mercury concentrations on liver enzyme levels.
We also assessed the mediation effect of oxidative stress
on the relationship between mercury exposure and
liver function because some studies suggested that
oxidative stress mediated mercury-induced hepatotox-
icity in rats [21].
Methods
Study population
We recruited 560 participants who regularly visited a
community welfare center located in Seongbuk-gu,
Seoul, Korea. The inclusion criteria were an age of
60 years or older, the ability to communicate with inter-
viewers and volunteered to participate in the study. Fast-
ing blood was collected up to five times (from August to
December 2008, from April to October 2009, from
March to August 2010, from October 2012 to June
2013, and from October 2013 to June 2014) from each
participant. Recruitment period was from 2008 to 2010
and follow-up period was from 2009 to 2014. Additional
file 1: Figure S1 showed a detail of recuitment and
follow-up. Information on demographic characteristics,
health behavior and medical history and a food fre-
quency questionnaire to assess dietary intake for the past
year was obtained at the time of enrollment. Our study
design was a panel study that we collected repeated
measures (blood mercury and liver enzymes) from the
same sample at every visit.
We excluded participants who had chronic hepatitis,
acute hepatic disease, fatty liver and liver cancer and
those who lacked information for blood mercury concen-
trations and liver enzyme levels. A total of 550 individuals
and 1222 observations were included in the analysis.
Among the 550 participants, 173, 177, 140, 25 and 35 in-
dividuals had blood samples collected once, twice, three
times, four times and five times, respectively.
The study protocol was approved by the institutional
review board at Seoul National University Hospital,
Seoul, Republic of Korea (IRB no. C-1209-006-424), and
each study participant provided written informed con-
sent. This study was performed in accordance with the
Declaration of Helsinki.
Measurement of blood mercury
To measure mercury concentrations in blood, 1 ml of
whole blood was drawn from each participant and then
sealed in a heparin containing tube (EDTA tube by BD
REF 367856). The blood samples were stored at − 70 °C
until analysis. The sample was initially dried in an oxygen
stream passed through a quartz tube located inside a con-
trolled heating coil. The combustion gases were further
decomposed on a catalytic column at 750 °C. Mercury
vapor was collected on a gold amalgamation trap and then
desorbed for quantification. Blood mercury concentration
was determined by flow injection cold-vapor atomic
absorption spectrometry (AAS) (DMA-80, Milestone,
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Bergamo, Italy). The laboratory analyses were performed
using standardized quality-control procedures. An internal
control was used for each series of analyses. The validity
of the mercury level measurement was verified by period-
ically participating in an external quality control program
(the German external quality assessment scheme (G-
EQUAS) and the CDC’s Lead and Multi-element Profi-
ciency (LAMP) program). The limit of detection (LOD)
was 0.158 μg/L, and no sample had a mercury level
below the LOD.
Obesity and lifestyle measurement
Trained health technicians measured body weight (kg)
and height (cm) following standardized procedures for
all participants. Body mass index (BMI) was calculated
as body weight in kilograms divided by height in meters
squared. Overweight was defined as 25 kg/m2 or higher
using the World Health Organization (WHO) criteria
[22]. Study participants were also split into three groups
by smoking status: less than 20 packs in lifetime smok-
ing (non-smoker), greater than 20 packs in lifetime and
don’t smoke now (previous smoker), and greater than 20
packs in lifetime and smoke now (current smoker). We
used only two categories for alcohol consumption:
“regular drinkers and non-drinkers”.
Liver enzyme measurement
Blood samples (up to 3 mL) were collected from each
participant at every visit using a BD vacutainer (Becton
Dickinson, Franklin Lakes, New Jersey, USA) containing
K2EDTA (Becton Dickinson) and preserved at −70 °C.
Serum AST, ALT and GGT were subsequently analyzed
by an autobiochemical analyzer (Hitachi 7600-II, Hitachi
High-Technologies Co., Tokyo, Japan). Pureauto S AST,
Pureauto S ALT, and Pureauto S GGT (Daiichi Pure
Chemicals, Tokyo, Japan) were used as reagents.
Measurement of malondialdehyde
We measured urinary levels of malondialdehyde (MDA)
as an oxidative stress biomarker. Urinary MDA levels
were determined by measuring thiobarbituric acid react-
ive substances as follows: 50 μl of urine was mixed with
300 μl of 0.5 M phosphoric acid solution and 150 μl of
23 mM TBA solution (Sigma-Aldrich T-5500, Steinheim,
Germany) and heated at 95 °C for 1 h. After cooling on
ice, the mixture was vortexed with 500 μl of methanol
and centrifuged at 5000 × g. Absorbance of the super-
natant was measured at 532 nm using HPLC–UV. The
mobile phase was potassium phosphate (0.05 mol/L;
pH 6.8) and methanol (58:42, v/v).
Statistical analysis
Because the concentrations of the three liver enzymes
were not normally distributed, log-transformed values
were used in the analysis. The geometric means (GMs)
(95% confidence interval (CI)) of blood mercury were
calculated by demographic characteristics. Blood mer-
cury levels were divided into quartiles. Abnormal liver
function tests were defined as serum AST >34 U/L in
men and >40 U/L in women; serum ALT >35U/L in
both men and women; and serum GGT >48 U/L in men
and >29 U/L in women [23].
We performed a multivariate analysis using a general-
ized estimating equations (GEE) model with exchange-
able correlation structure to estimate the effects of
blood mercury on liver function taking account for cor-
related structure of data due to repeated measures over
time. We modeled log-transformed liver enzyme levels
as a normal distribution and abnormal liver function as
a binomial distribution.
We adjusted potential confounder which were consid-
ered as a confounders in previous epidemiologic study
[17] (age [years], sex [male and female], overweight
[BMI ≥ 25 kg/m2], alcohol consumption [regular drinkers
or non-drinkers], smoking [nonsmoker, previous smoker,
current smoker], education [≤elementary school graduate,
≥middle school graduate]) or variables which was associ-
ated with nonalcoholic fatty liver disease (high-density li-
poproteins (HDL) cholesterol [mg/dL], regular exercise
[yes or no] and total calorie intake [kcal]) [24, 25].
Alcohol intake is a important risk factor for liver dis-
ease [26], if there is an interaction between alcohol and
mercury for liver function, people with high mercury
levels should limit alcohol intake even more. To evaluate
the interaction effects of alcohol consumption in the as-
sociation between mercury concentrations and liver
function, we used median for mercury cut-off concentra-
tion (men = 3.77 μg/L; women = 2.59 μg/L). We stratified
data into four groups (non-drinkers and low mercury
level, non-drinkers and high mercury level, regular
drinkers and low mercury level, and regular drinkers
and high mercury level), and estimated odds ratio (OR)
of having abnormal liver function compared to the refer-
ence group (non-drinkers and low mercury level).
To test the mediation effect of oxidative stress on the
association between mercury concentrations and liver
enzyme levels, we used multiple linear regression models
and mediaiton analysis that was developed in SAS macros
by Jasti et al. [27] based on the formula of Mackinnon and
Dwyer [28]. After assessing the linear relationship of blood
mercury levels with oxidative stress and liver function, a
Sobel test [29] was conducted for testing the significance
of a mediation effect. Mercury levels were used as expos-
ure variables and MDA for oxidative stress was used as
mediators. Log-transformed liver enzyme levels were used
as the outcome variables. The mediation analysis was con-
ducted on all participants, then non-drinkers and regular
drinkers, separately.
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To visualize a linear relationship, we used generalized
additive mixed models of R (package ‘gamm4’) with
cubic smoothing spline (k = 3).
All of the analyses applied two-sided tests, and we
considered a p-value lower than 0.05 to be significant.
Statistical analyses were conducted using R version
2.15.2 (The Comprehensive R Archive Network: https://
cran.r-project.org/) and SAS software version 9.3 (SAS
Institute Inc., Cary, NC, USA).
Results
Participants’ characteristics and geometric mean (95% CI)
mercury levels at the first visit are shown in Table 1.
The mean age of 550 participants was 70.7 years (range,
60–87 years), and the ratio of men to women was ap-
proximately one to three. Men, ages 60–69 years,
higher education attainment, overweight, regular alco-
hol drinkers, and higher calorie intake showed higher
total blood mercury. Participants who had higher blood
mercury levels were significantly higher in abnormal
AST and ALT (p < 0.05).
The arithmetic and geometric mean, minimum, max-
imum, quartiles of blood mercury at each visit are
shown in Additional file 1: Table S1. The arithmetic and
geometric mean of mercury in all samples were 3.29 and
2.81 μg/L, respectively.
When adjusted by sex, age, smoking status, drinking
status, exercise, education, HDL cholesterol, overweight,
and calorie intake using the GEE model, those with the
4th quartile of blood mercury showed significantly
higher AST and ALT compared to those with 1st quartile
of blood merury, and those with the 3th or 4th quartiles
of blood mercury had significantly higher GGT com-
pared to those with the first quartile (Table 2).
Results observed using dichotomized outcomes for
serum liver enzymes (normal vs. abnormal) are shown in
Table 3. Among individuals who had the highest quartile
of total blood mercury levels, the OR of having abnor-
mal ALT level was 3.10 (95% CI 1.17–8.24) compared to
those with the lowest quartile.
The interactive effect of blood mercury level in the rela-
tionship between alcohol consumption and abnormal
liver function (AST, ALT and GGT) is shown in Fig. 1.
The group with high mercury level and regular alco-
hol consumption habit showed significantly high OR
of having abnormal GGT (OR 2.37, 95% CI 1.19–
4.69) compared to the reference group (non-drinkers
and those with low mercury level) with an interaction
P-value < 0.001.
The measures of mediation for MDA in the relation-
ship between blood mercury levels and liver enzymes in
all participants and the non-drinker group are presented
in Table 4. For both all participants and non-drinking
group, MDA was not significantly mediated.
Table 1 Geometric mean and 95% confidence intervals of blood
mercury levels by participant characteristics at the first visit
Characteristic No. GM (95% CIs) p-value
Total 550 2.78 (2.65, 2.92)
Age (years)
60–69 246 3.31 (3.10, 3.54) <.0001
70–79 281 2.70 (2.55, 2.87)
80- 23 1.99 (1.49, 2.64)
Sex
Men 141 3.67 (3.36, 4.00) <.0001
Women 409 2.70 (2.57, 2.84)
Education
≤ Elemental school graduate 303 2.68 (2.52, 2.84) <.0001
≥Middle school graduate 231 3.28 (3.07, 3.51)
Missing 16
BMI (kg/m2)
< 25 308 2.79 (2.62, 2.98) 0.015
≥ 25 242 3.09 (2.91, 3.29)
Cigarette smoking
Non smoker 472 2.86 (2.73, 3.01) 0.077
Previous smoker 34 3.41 (2.88, 4.03)
Current smoker 29 3.32 (2.81, 3.93)
Missing 15
Alcohol
Non-drinker 414 2.78 (2.64, 2.92) <.0001
Regular drinker 119 3.48 (3.14, 3.87)
Missing 17
AST (U/L)
Men:≤34; Women:≤40 532 2.90 (2.77, 3.03) 0.007
Men:>34; Women:>40 18 3.74 (3.15, 4.45)
ALT (U/L)
≤ 35 513 2.87 (2.74, 3.01) 0.003
> 35 37 3.75 (3.23, 4.36)
GGT (U/L)
Men:≤48; Women:≤29 461 2.87 (2.74, 3.02) 0.097
Men:>48; Women:>29 89 3.18 (2.84, 3.57)
HDL-Cholesterol (mg/dL)
Men:<40; Women < 50 328 2.97 (2.81, 3.14) 0.344
Men:≥40; Women≥ 50 222 2.85 (2.64, 3.07)
Energy intake (Kcal)
< 2000 262 2.76 (2.60, 2.94) 0.014
> 2000 188 3.13 (2.89, 3.40)
Missing 100
Student’s t-test and ANOVA (analysis of variance) used to compare means
across categories
Abbreviations: ALT Alanine transaminase, AST aspartate aminotransferase, BMI
body mass index, CIs confidence intervals, GGT Gamma-glutamyl transferase;
GM, geometric mean
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We showed linear relationship between blood mercury
and liver function using generalized additive mixed
model in Additional file 1: Figure S2.
Discussion
To our knowledge, this was the first study using re-
peated measurements which considered within-person
change of mercury exposure and liver function across
time. The findings of the present study suggest that total
blood mercury levels were associated with elevated liver
enzyme concentration in the elderly. We also found an
interaction effect of alcohol consumption and mercury
concentration on liver function. Fatty liver changes ac-
companied by increased BMI may contribute partly to
liver function impairment in the association with mer-
cury exposure within non-drinkers. A mediation analysis
was performed to demonstrate the mechanism of mer-
cury’s effect on liver function. In our study, oxidative
stress, which was suggested from another study in rat
[21, 30], was not found to mediate the interaction be-
tween mercury and liver function.
The geometric mean of total blood mercury levels in
the present study was 2.81 μg/L (2.73, 2.89), which was
relatively higher than the levels from other countries’
surveys. The geometric mean for total blood mercury
was 0.23 μg/L in the German Environmental Survey IV
(2003–2008) [31]. In the study based on the 2011–2012
NHANES, the geometric mean of total blood mercury
level was 0.70 (0.62–0.80) μg/L [men 0.71 (0.62–0.81)
μg/L, women 0.69 (0.61–0.79) μg/L], and the Asian
group had the highest blood mercury level [1.86 μg/L
(1.58, 2.19)] [19] among the US population. Our study
participants had lower blood mercury concentration,
compared to KNHANES (2008–2012) [men 5.07 (5.00–
5.14) μg/L and women 3.59 (3.55–3.63) μg/L] [20].
The present findings also supported some previous ep-
idemiologic studies. Cave et al. [16] showed that whole
blood mercury level was associated with ALT elevation
in NHANES 2003–2004. Those authors suggested that
the organic form (methylmercury) of mercury was asso-
ciated with liver disease. Lee et al. [17] reported that the
OR of having serum AST and ALT levels higher than the
median among subjects in the highest quartile of blood
mercury were 1.53 (1.26–1.85) and 1.95 (1.63–2.33)
compared to the lowest quartile, respectively, using the
2008–2012 KNHANES. Seo et al. [18] demonstrated that
the adjusted OR (95% CI) for high GGT in the highest
quartile compared to the lowest quartile of blood mer-
cury levels was 2.59 (1.51–4.43) in men and 2.03 (1.13–
3.67) in women using the 2010 KNHANES.
Although the mechanism of mercury-induced hepato-
toxicity has not been clarified, some studies suggested
that mercury produces reactive oxygen species and de-
presses antioxidant system components, and the result-
ing oxidative stress triggers hepatotoxicity [12, 13, 32].
In the present study, when we performed a mediation
analysis for oxidative stress biomarkers, we could not
find significant results in all of the participants or the
non-drinker group.
Alcohol consumption is a major risk factor for liver
disease, and one-third of liver cirrhosis cases are attrib-
utable to heavy alcohol consumption [26]. However,
there was still a significant mercury effect on liver func-
tion when alcohol consumption was adjusted in the
multivariate model. We also observed a significant asso-
ciation between the highest quartile of mercury levels
and ALT in the non-drinker group (Additional file 1:
Table S2). In addition, we found the interaction between
alcohol consumption and mercury exposure for liver
function. WHO reported that alcohol per capita con-
sumption in Korea was 12.3 l, which is higher than 6.2 l
in world [33]. Mercury level in Koreans is also higher
than most other countries [34]. Therefore, liver dysfunc-
tion could be more prevalent among Koreans, particu-
larly with alcohol drinking and high mercury level.
Table 2 Estimated association of log transformed liver enzyme
and blood total mercury using GEE model
Mercury AST ALT GGT
Estimate p-value Estimate p-value Estimate p-value
Q1 Ref Ref Ref
Q2 0.01 (0.02) 0.733 0.04 (0.03) 0.204 0.04 (0.03) 0.201
Q3 0.03 (0.03) 0.228 0.04 (0.03) 0.184 0.08 (0.04) 0.044
Q4 0.07 (0.03) 0.027 0.12 (0.04) 0.002 0.12 (0.04) 0.008
Covariates: sex, age, smoking status, drinking status, exercise, education,
high-density lipoproteins cholesterol, overweight and calorie
Abbreviations: ALT Alanine transaminase, AST aspartate aminotransferase, GEE
generalized estimating equations, GGT Gamma-glutamyl transferase, Q quartile:
1st Q (<2.50 for men, <1.86 for women), 2nd Q (2.50 ≤ and <3.77 for men, 1.86 ≤
and <2.59 for women), 3rd Q (3.77 ≤ and <5.41 for men, 2.59 ≤ and <3.53 for
women), 4th Q (≥5.41 for men, ≥3.53 for women)
Table 3 Odds ratios of liver function tests to total blood
mercury using GEE model
Mercury AST ALT GGT
OR 95% CI OR 95% CI OR 95% CI
Abnormal liver test
Q1 Ref Ref Ref
Q2 1.30 0.41–4.11 2.01 0.83–4.90 1.34 0.86–2.07
Q3 1.68 0.49–5.76 2.05 0.77–5.43 1.02 0.62–1.67
Q4 2.70 0.95–7.68 3.10 1.17–8.24 1.29 0.79–2.13
Covariates: sex, age, smoking status, drinking status, exercise, education,
high-density lipoproteins cholesterol, overweight, calorie
Abbreviations: ALT Alanine transaminase, AST aspartate aminotransferase, CI
confidence interval, GEE generalized estimating equations, GGT Gamma-glutamyl
transferase, Q quartile: 1st Q (<2.50 for men, <1.86 for women), 2nd Q (2.50 ≤ and
<3.77 for men, 1.86 ≤ and <2.59 for women), 3rd Q (3.77 ≤ and <5.41 for men,
2.59 ≤ and <3.53 for women), 4th Q (≥5.41 for men, ≥3.53 for women), OR
odds ratio
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Our results showed that blood mercury concentrations
are most associated with ALT among the three liver en-
zymes. Both AST and ALT are released from damaged
hepatocytes into the blood, but AST is also released
from several non-hepatic tissues including the heart,
skeletal muscle and blood. ALT is more specific to hepa-
tocellular liver injury and disease [35]. GGT is the en-
zyme that catalyzes the hydrolysis of glutathione and
transfer of the γ-glutamyl group from one peptide to an-
other or to an amino acid in the liver [36]. Because the
blood level of GGT is a more sensitive biomarker for al-
cohol consumption [37] than ALT and AST, GGT was
appropriate for revealing the synergistic effect between
alcohol and mercury on liver function.
The present study has some limitations. First, this
study was conducted in an elderly population; thus, the
results cannot be generalized to general population.
Also, we recruited participants at only one center in
Seoul, didn’t randomly select the participants or didn’t
use systematized sampling procedures. So this data is
not representative sample in relation to the South
Korean elderly population. Second, although we used re-
peated analysis, we could not exclude the possibility of
reverse causation. Lin et al. [38] found that MeHg repre-
sents a higher fraction of the total circulating Hg among
those with elevated all three liver enzyme (AST, ALT
and GGT) using NHANES 2003–2008. They explained
that compromised liver function may result in decreased
demethylation and therefore an increased organic frac-
tion (MeHg) of blood total Hg. Third, we measured only
total Hg in blood and we did not measure organic mer-
cury. Mortensen et al. [19] showed that the NHANES
2011–2012 provided data to examine total, inorganic,
methyl, and ethyl mercury directly in whole blood. And
they found that total Hg and MeHg concentrations were
highly correlated, and the ratio of MeHg to THg was
higher for Asians (0.85). So blood tests are generally
used to measure the organic mercury because of the
high rate of uptake of methylmercury in red blood cells
[39]. Fourth, although we excluded participants with
Fig. 1 Odds ratios for abnormal AST, ALT, and GGT by blood mercury using generalized estimating equations model. Abbreviations: ALT, Alanine
transaminase; AST, aspartate aminotransferase; GGT, Gamma-glutamyl transferase; Q, quartile; OR, odds ratio
Table 4 Tests and measures of mediation for MDA in the relationship between mercury and liver function
Mediation variable Outcome Indirect effect S.E P value for Sobel test Percent (%) of the total
effect that is mediated
All participants
MDA AST 1.0× 10−5 6.3× 10−5 0.872 11.92
ALT −1.2× 10−5 7.3× 10−5 0.873 12.17
GGT 1.0× 10−5 6.6× 10−5 0.879 19.38
Non-drinkers
MDA AST 1.1× 10−4 3.2× 10−4 0.735 3.24
ALT −2.2× 10−4 4.1× 10−4 0.583 7.37
GGT 1.2× 10−5 3.3 × 10−4 0.971 27.29
Abbreviations: ALT Alanine transaminase, AST aspartate aminotransferase, BMI body mass index, CI confidence interval, GGT Gamma-glutamyl transferase,
MDA Malondialdehyde, S.E standard error
Lee et al. Environmental Health  (2017) 16:17 Page 6 of 8
chronic hepatitis, acute hepatic disease, fatty liver and liver
cancer, it is possible that we may have included partici-
pants who had mild liver dysfunction caused by the other
factors than mercury exposure. Fifth, information on fish
intake was not available, therefore, it couldn’t be adjusted
in analysis. Sixth, in mediation analysis, SAS macros by
Jasti et al. based on the formula of Mackinnon and Dwyer
did not provide correlation structure, so all variable was
considered independent. Finally, we used only two cat-
egories for alcohol consumption: “regular drinkers and
non-drinkers”. We couldn’t calculate alcohol consumption
per week so we couldn’t classify into heavy drinker or
moderate drinker.
Conclusions
We conducted repeated measurements of total blood
mercury to evaluate the effect of environmental expos-
ure to mercury on liver function in an elderly popula-
tion. Our findings suggest that exposure to mercury
increase the risk of liver function abnormality and inter-
act with alcohol consumption for elevating the risk.
Additional file
Additional file 1: Table S1. Distribution of mercury at each visit and
overall study. Table S2. Estimated association between log transformed
liver enzymes and total blood mercury levels using generalized estimating
equations model in non-drinkers. Figure S1. Flow chart for study
participants. Figure S2. Generalized additive mixed model for total
mercury concentrations and three liver enzymes. Additionally adjusted for
sex, age, smoking status, drinking status, exercise, education, high-density
lipoproteins cholesterol, overweight and calorie. (PDF 147 kb)
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